Announcements

10 January 2025
Receptors | Aims and Scope Update

To further enhance the quality of Receptors and the papers published in it, under the guidance of our Editor-in-Chief, Prof. Dr. Stephen H. Safe, the journal has updated and revised its aims and scope. The original scope and the updated version are listed below:

Aims (new version):

Aims (old version):

Receptors (ISSN: 2813-2564) is an international, peer-reviewed, open access journal that publishes novel research findings, reviews, and communications covering all aspects of receptor structure and function, molecular biology and genetics, signaling and interactions, and their physicochemical/biophysical properties. This journal focuses on publishing Research Articles, Reviews, Communications, and Editorials, but other article types will also be considered. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the maximum length of papers. In order for the results to be reproduced, full experimental details must be provided, and the journal will make full use of supplementary electronic material where appropriate.

Receptors (ISSN: 2813-2564) is an international, peer-reviewed, open access journal that publishes novel research findings, reviews, and communications covering all aspects of receptor structure and function, molecular biology and genetics, signaling and interactions, and their physicochemical/biophysical properties. It publishes Research Articles, Reviews, Communications and Editorials. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the maximum length of papers. In order for the results to be reproduced, full experimental details must be provided, and the journal will make full use of supplementary electronic material where appropriate.

Scope (new version):

Scope (old version):

  • Receptor structure, subunits and complexes;
  • Receptor function and oligomerization;
  • Receptor signaling;
  • Receptor interactions with drugs, receptors, ligands, chemokines, viruses, and proteins;
  • Receptor expression and regulation;
  • Computational modeling, physicochemical and biophysical properties of receptors;
  • Receptors in designing drugs, diagnosis and therapy;
  • Nuclear receptors in diseases, reproduction, development and metabolism;
  • Receptor mutations and outcomes.
  • Receptor structure, subunits and complexes;
  • Receptor function and oligomerization;
  • Receptor signaling;
  • Receptor interactions with drugs, receptors, ligands, chemokines, viruses, and proteins;
  • Receptor expression and regulation;
  • Computational modeling, physicochemical and biophysical properties of receptors;
  • Receptors in designing drugs, diagnosis and therapy;
  • Nuclear receptors in diseases, reproduction, development and metabolism.

For more detailed information, please visit the following link: https://www.mdpi.com/journal/Receptors/about.

Receptors Editorial Office

More News...
Back to TopTop